Independent report
Vivaldi 3: Boosters strongly enhance SARS-CoV-2 antibody and cellular responses in elderly residents in care homes
Report setting out the results of a study of 124 staff and residents in 19 long term care homes who have received an mRNA booster following 2 doses of either Pfizer or AstraZeneca between May and November 2021
Documents
Details
The Vivaldi 3 study, conducted by the University of Birmingham in collaboration with University College London, is an integral part of the Vivaldi project which was set up in June 2020 to investigate SARS-CoV-2 transmission, infection outcomes and immunity in residents and staff in care homes in England.
Published 23 December 2021